NCT01125371

Brief Summary

African American (AA) women are disproportionately affected by HIV/AIDs. The major risk factor for HIV acquisition among AA women is high-risk heterosexual sex, including unprotected vaginal and anal sex, and sex with a high-risk partner. Hazardous alcohol use has been associated with high risk sexual behaviors and prevalent gonorrhea among women attending an urban STI clinic, both of which increase a woman's vulnerability to HIV acquisition and transmission. This application proposes a randomized controlled trial (RCT) of a culturally tailored computer-directed brief alcohol intervention (CBI) enhanced with cell-phone booster calls using interactive voice response technology (IVR) and text messages among HIV-infected and at-risk AA women attending an urban STI Clinic. Hazardous drinking AA women (N=450) presenting with STI complaints will be randomized to one of three arms: 1) usual clinical care, 2) clinic-based, CBI, or 3) clinic-based, CBI + 3 booster calls using IVR and text messages. The CBI, an evidence-based based method for behavior change, will use principles of motivational interviewing, to counsel on: 1) alcohol use and 2) associated HIV/STI risk behaviors. Primary outcomes, measured at 3, 6, and 12 month intervals, include alcohol-related risk behaviors (number of binge drinking episodes, drinking days/week, and drinks per occasion), sexual risk behaviors (number of partners, episodes of unprotected vaginal/anal sex, episodes of sex while high), and occurrence of HIV/STI biomarkers. Prior to implementing the RCT, the CBI and IVR software messages will be revised to: 1) include the association between hazardous alcohol use and risky sexual behaviors, and 2) ensure their relevance and acceptability using quantitative/qualitative feedback from a sample of AA women attending a Baltimore City STI clinic. The proposed research focuses on a particularly vulnerable population of urban HIV at-risk and HIV-infected AA women seeking treatment in a public STI clinic and examines two novel BI intervention delivery strategies specifically tailored to be culturally/socially relevant to this minority population. If the intervention(s) prove to be effective, study findings will offer "real life" specialty care clinics a screening and intervention package that is practical, low cost, and easy to implement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
439

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 18, 2010

Completed
1.4 years until next milestone

Study Start

First participant enrolled

October 1, 2011

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2016

Completed
6 years until next milestone

Results Posted

Study results publicly available

June 24, 2022

Completed
Last Updated

June 24, 2022

Status Verified

June 1, 2022

Enrollment Period

4.7 years

First QC Date

May 17, 2010

Results QC Date

June 1, 2022

Last Update Submit

June 1, 2022

Conditions

Keywords

Hazardous alcohol useBinge drinkingHigh risk sexual behaviorsHIV risk reduction

Outcome Measures

Primary Outcomes (4)

  • Change in Alcohol Use (Heavy Drinking Days)

    Change in alcohol-related risk behavior as assessed by the number of heavy drinking days.

    Baseline, 3, 6, and 12 months

  • Change in Alcohol Use (Drinking Days)

    Change in alcohol-related risk behavior as assessed by the number of drinking days.

    Baseline, 3, 6, and 12 months

  • Change in Alcohol Use (Drinks Per Drinking Day)

    Change in alcohol-related risk behavior as assessed by the standard drinks per drinking day.

    Baseline, 3, 6, and 12 months

  • Change in Alcohol Use (Drinks Per Week)

    Change in alcohol-related risk behavior as assessed by the standard drinks per week.

    Baseline, 3, 6, and 12 months

Study Arms (3)

Computerized Brief Alcohol Intervention + IVR

EXPERIMENTAL

Computer-delivered brief alcohol intervention (CBI) with booster phone calls delivered by IVR+ text messages (TM)

Behavioral: Computerized brief alcohol intervention + IVR booster calls

Computerized Brief Alcohol Intervention

ACTIVE COMPARATOR

Computerized Brief Alcohol Intervention only (CBI)

Behavioral: Computerized brief alcohol intervention

Attention Control

PLACEBO COMPARATOR

Attention control

Behavioral: Attention Control

Interventions

1\) Computerized brief alcohol intervention + IVR booster calls: Clinic-based computerized brief alcohol intervention (delivered once) followed by three booster phone calls using interactive voice response technology + text messages

Also known as: CBI+IVR+TM
Computerized Brief Alcohol Intervention + IVR

Computerized brief alcohol intervention: Clinic based computer delivered brief alcohol intervention delivered one time

Also known as: CBI
Computerized Brief Alcohol Intervention

Attention Control: 20 minute attention control condition focused on dental hygiene delivered once

Attention Control

Eligibility Criteria

Age18 Years - 90 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older;
  • HIV infected or HIV negative and attending the Baltimore City Health Department sexually transmitted infection clinic for STI-related services
  • Consumes an average of 8 or more drinks per week OR has had two binge drinking episodes (4 drinks/occasion) in the last 3 months
  • sexually active
  • Cognitively able to understand proposed research design (10 min screening, followed by random assignment to one of three study groups (if individual fulfills criteria for RCT enrollment);
  • Able to speak and understand English
  • Able and willing to receive text messages

You may not qualify if:

  • Pregnant women will be excluded and referred directly to social work for referral to either alcohol or drug treatment due to ethical concerns of randomization to usual care.
  • Currently enrolled in alcohol or drug treatment.
  • Non-English Speaking.
  • Actively Psychotic or have other severe mental health symptoms that would prevent appropriate participation in the brief intervention protocol.
  • Planning on moving out of the area within 12 months of study entry

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore City Health Department STD Clinic

Baltimore, Maryland, 21205, United States

Location

MeSH Terms

Conditions

Binge DrinkingRisk-TakingHIV Infections

Interventions

EthanolMethods

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersAlcohol DrinkingDrinking BehaviorBehaviorMental DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic ChemicalsInvestigative Techniques

Results Point of Contact

Title
Dr. Geetanjali Chander
Organization
Johns Hopkins University

Study Officials

  • Geetanjali Chander, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2010

First Posted

May 18, 2010

Study Start

October 1, 2011

Primary Completion

June 7, 2016

Study Completion

June 7, 2016

Last Updated

June 24, 2022

Results First Posted

June 24, 2022

Record last verified: 2022-06

Locations